Michel Baudry, PhD, CEO. Dean, Graduate College of Biomedical Sciences at Western University of Health Sciences; former professor of biological sciences, neurology and biomedical engineering at University of Southern California; internationally known neuroscientist who has published more than 350 manuscripts in peer-reviewed journals; one of the 100 most-cited neuroscientists in the world, according to the ISI database; served on numerous National Science Foundation and National Institutes of Health studies; graduated from Ecole Polytechnique, Paris in 1971; earned a PhD in biochemistry at University of Paris VII in 1977 under direction of professors J.C. Schwartz and J.P. Changeux, two of France's most distinguished neurobiologists.
Xiaoning Bi, MD, PhD, CSO. Professor of Physiology, College of Osteopathic Medicine of Pacific; Ph.D., Neurobiology, Neuroscience Program, University of Southern California, Los Angeles, CA, 1996, M.D., Neuroanatomy, Brain Research Institute, Zurich University, Switzerland, 1994, M.S., Neurophysiology, Third Military Medical University, P.R. China, 1986, M.D., Medicine, Binzhou Medical University, P.R. China, 1982, Postdoctoral Fellow, Dept. of Anatomy and Neurobiology, UCI, Irvine, CA, 1997-1998 & Postdoctoral Fellow, Neuroscience, USC 1996-1997. Dr. Bi has been collaborating with Dr, Baudry on the calpain project since 1996.
Gregory C. DiRienzo, co-founder and CEO, New Life Cancer Centers, (newlifecancercenteres.com); founder, CEO of ProGenaCell, Inc. (progenacell.com), an international stem cell healthcare provider; founder and CEO of Medici Integrative Health & Surgery Center (medicicenterintegrativehealth.com); founder, CEO of New Cell Sciences, a biomedical research and development company, former CEO of PDA Solutions, an innovative medical software company; former Managing Partner of Bailey, Charles & Gregory, a civil and criminal litigation consulting firm; institutional banker; B.Sc. California State University San Diego; post-graduate studies in international finance and banking.
Bernard Malfroy-Camine, PhD. 30+ years experience in biotech (Genentech, Alkermes, Eukarion, MindSet Rx); Bicultural (American & French); Serial biotech entrepreneur, founder of Eukarion and MindSet Rx (US), member of the founding Board of Directors of Genomic Vision and Emosis Diagnostics (France), member of the Board of EyeGate Pharma and ViThera Pharmaceuticals (US), Foreign Trade Adviser to the French Government.
Yubin Wang, PhD. Research Assistant Professor (GCBS). BS in Biotechnology from Hebei University, PRC; PhD in Neuroscience from Zheijang University, PCR. Responsible for many of the experimental results over the last 3 years.
Steve Standley, PhD, Assistant Professor (GCBS), PhD in Neuroscience from USC, Post-doctoral fellowship at NIH; Patent Examiner at the USPTO; Tech Transfer Office at the NIH, where he managed and negotiated licensing for an early invention portfolio worth tens of millions of dollars. Dr. Standley has a broad range of expertise in chemistry and in translational biomedical sciences.
Lyna Luo, PhD, Assistant Professor, College of Pharmacy, WUHS. Computational medicinal chemist. Dr. Luo is using computational chemistry to identify more selective calpain-2 inhibitors.